Filip Lauc

Filip Lauc serves as Chief Technology Officer at GlycanAge. GlycanAge operates in the biotechnology sector with approximately 43.0 employees.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • We have verified contacts for 2 executives at GlycanAge.
• • Our database includes 201,468 c suite-level executives.

Gmail Google Apps Stripe Hubspot Digital Ocean DNS Linkedin Marketing Solutions Google Font API Mobile Friendly WordPress.org Facebook Custom Audiences reCAPTCHA Facebook Widget DoubleClick Conversion Google Dynamic Remarketing Intercom DoubleClick Facebook Login (Connect) YouTube Google Tag Manager AI

biological age test chronic inflammation glycan analysis home testing kit healthspan optimization wellness consultation personalized health advice biomarker assessment biohacking tools health improvement menopause management precision medicine scientific research glycan biomarkers immune system health health tracking lifestyle interventions data-driven health aging measurement nutrition influence pro-inflammatory markers anti-inflammatory responses glycome evaluation longitudinal health monitoring digital health solutions lab analysis health technologies chronic disease prevention epigenetic insights scientific publications biological aging lifestyle assessment health optimization glycan testing track aging biological clock health programs inflammation measurement consultation services age reversal health metrics glycoscience personal wellness health indicators weight management guidance genetic health influence sugar molecule assessment health analytics evidence-based health solutions

ZD

Zorrie Dimitrova Chief Operating Officer at GlycanAge

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Filip Lauc, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Filip Lauc's Position in the MessageCEO Database

• •Filip Lauc is 1 of 2 verified executive contacts we track at GlycanAge.
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •11 verified contacts work at biotechnology companies in the 43.0 employee range (same size as GlycanAge).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Filip Lauc directly?

Filip Lauc's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at GlycanAge. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Filip Lauc work for?

Filip Lauc is Chief Technology Officer at GlycanAge, a company in the biotechnology sector with 43.0 employees.

Can I pitch or sell to Filip Lauc?

As Chief Technology Officer at GlycanAge, Filip Lauc is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Filip Lauc directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Filip Lauc in?

Filip Lauc works in the biotechnology industry as Chief Technology Officer at GlycanAge. MessageCEO provides verified contact information for executives across all major industries.

Is Filip Lauc's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Filip Lauc's profile is kept up-to-date with the latest available information.

Last updated: July 25, 2026